Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

1.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.1K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

333
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
333

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Is the Utility of 7 Tesla MRI for Deep Brain Stimulation Surgery? A Scoping Review.

Stereotactic and functional neurosurgery·2026
Same author

Choice of Neurosurgical Planning Software Affects Deep Brain Stimulation Target Coordinate Generation.

Stereotactic and functional neurosurgery·2026
Same author

A case report exploring the use of subcutaneous Botox for the treatment of neuropathic pain in active head and neck cancer.

Pain management·2026
Same author

Between Surgery and Science: Patient Journeys in Deep Brain Stimulation Local Field Potential Research.

Neuromodulation : journal of the International Neuromodulation Society·2026
Same author

YouTube videos for describing Deep Brain Stimulation: a comprehensive and quantitative review.

British journal of neurosurgery·2026
Same author

Multidisciplinary management of persistent severe cancer pain: a collaborative European approach.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025

Related Experiment Video

Updated: Nov 9, 2025

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.1K

Neuromodulation techniques for cancer pain management.

David J Magee1,2, John Schutzer-Weissmann2, Erlick A C Pereira3,4

  • 1Signalling and Cancer Metabolism Team, Division of Cancer Biology, The Institute of Cancer Research.

Current Opinion in Supportive and Palliative Care
|April 12, 2021
PubMed
Summary

Intrathecal drug delivery (ITDD) and neuromodulation offer advanced cancer pain management options. These techniques are underutilized in the UK but show promise for patients with refractory pain or side effects.

More Related Videos

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:03

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

770
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.4K

Related Experiment Videos

Last Updated: Nov 9, 2025

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.1K
Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:03

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

770
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

2.4K

Area of Science:

  • Pain Management
  • Oncology
  • Neuromodulation

Background:

  • 5-15% of cancer patients require advanced pain management.
  • Current UK procedures for cancer pain analgesia and ITDD implantation are notably low.
  • Significant unmet clinical need exists for effective cancer pain management.

Purpose of the Study:

  • To review emerging evidence for intrathecal drug delivery (ITDD) in cancer pain.
  • To provide a narrative review of other neuromodulatory techniques for cancer pain.
  • To highlight the underutilization of these advanced techniques in the UK.

Main Methods:

  • Literature review of recent studies on ITDD for cancer pain.
  • Narrative review of neuromodulatory techniques: spinal cord stimulation, peripheral nerve stimulation, and acupuncture.
  • Analysis of current UK practices in advanced cancer pain management.

Main Results:

  • Recent studies report positive outcomes for ITDD in cancer pain management.
  • The evidence base for neuromodulation in cancer pain is growing but remains sparse compared to non-malignant pain.
  • ITDD and neuromodulation are underutilized in the UK.

Conclusions:

  • ITDD and neuromodulatory techniques offer potential for improved cancer pain management.
  • These advanced methods can benefit cancer patients with refractory pain or severe side effects from systemic analgesics.
  • Increased utilization of ITDD and neuromodulation is warranted in the UK.